Speaker
Co-Founder, Scientific Advisor & Board Director, Syrna Therapeutics Inc
Thomas Hermann, Co-Founder, Scientific Advisor & Board Director at Syrna Therapeutics Inc, is speaking at 9th RNA-Targeted Drug Discovery & Development Summit (Boston, United States of America, 10–12 Nov 2026) in the session “Rational, Structure-Guided Design of Small Molecule Covalent Translation Inhibitors Targeting mRNA”.
10–12 Nov 2026Boston, United States of America
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Thomas Hermann, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].